Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation
ZM Younossi - Liver Transplantation, 2018 - journals.lww.com
Nonalcoholic fatty liver disease (NAFLD), a common cause of chronic liver disease (CLD),
has a global prevalence of 25%. 1 Its progressive form, nonalcoholic steatohepatitis (NASH) …
has a global prevalence of 25%. 1 Its progressive form, nonalcoholic steatohepatitis (NASH) …
[PDF][PDF] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
ZM Younossi - Liver Transplantation, 2018 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD), a common cause of chronic liver disease (CLD),
has a global prevalence of 25%. Its progressive form, nonalcoholic steatohepatitis (NASH) …
has a global prevalence of 25%. Its progressive form, nonalcoholic steatohepatitis (NASH) …
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
ZM Younossi - Liver Transplantation, 2018 - cir.nii.ac.jp
抄録< jats: p> Nonalcoholic fatty liver disease (NAFLD), a common cause of chronic liver
disease (CLD), has a global prevalence of 25%. 1 Its progressive form, nonalcoholic …
disease (CLD), has a global prevalence of 25%. 1 Its progressive form, nonalcoholic …
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
ZM Younossi - Liver Transplantation: Official Publication of the …, 2018 - europepmc.org
Nonalcoholic fatty liver disease (NAFLD), a common cause of chronic liver disease (CLD),
has a global prevalence of 25%. Its progressive form, nonalcoholic steatohepatitis (NASH) …
has a global prevalence of 25%. Its progressive form, nonalcoholic steatohepatitis (NASH) …
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
ZM Younossi - … publication of the American Association for …, 2018 - pubmed.ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD), a common cause of chronic liver disease (CLD),
has a global prevalence of 25%. Its progressive form, nonalcoholic steatohepatitis (NASH) …
has a global prevalence of 25%. Its progressive form, nonalcoholic steatohepatitis (NASH) …